Pfizer (NYSE:PFE)

buy sell

4 Merrill Lynch Big, Old and Ugly Stocks To Buy For The Rest Of 2015

For the most part, unless you were way over-weighted to energy, large cap and mega cap stocks did reasonably well for investors this year. At the end of 2014 Savita ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More

Stocks were indicated higher on Wednesday ahead of the pending FOMC decision on interest rates. Tuesday's rally was yet another instance where investors proved that they want to buy stocks ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Lifted the Dow on Tuesday

July 28, 2015: Markets opened higher on Tuesday after the Shanghai market closed with a modest loss compared with Monday’s 8.5% dive. U.S. consumer confidence came in lower than expected ...
Read Full Story »
Pills

Pfizer Overcomes Currency Exchange Issue with Stronger Sales of Cancer Drugs

Pfizer Inc. (NYSE: PFE) reported second quarter 2015 results before markets opened Tuesday morning. The company reported quarterly adjusted diluted earnings per share (EPS) of $0.56 and revenues of $11.9 ...
Read Full Story »
Pfizer logo

What to Look For in Pfizer Earnings

Before the market opens on Tuesday morning, Pfizer Inc. (NYSE: PFE) is scheduled to report second-quarter results. The company is expected to post earnings per share (EPS) of $0.52 on ...
Read Full Story »
Prescription drugs

Short Sellers Run For Cover From Major Pharma

The short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
biotech

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

Pharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings from Dow Jones Industrial Average companies Merck & Co. Inc. ...
Read Full Story »
Eli Lilly Logo

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

While it appears at least for the time being that the Greek can once again has been kicked down the road, looking for solid more defensive stocks still makes good ...
Read Full Story »
Pills

Short Sellers Run for Cover in Big Pharma

The short interest data have been released for the June 30 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Boosted the DJIA on Thursday

July 9, 2015: Markets opened higher on Thursday and that’s when the major indexes posted their daily highs. New claims for unemployment benefits remain at close to the averages for ...
Read Full Story »
Pfizer logo

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

Anytime you see warning clouds hovering over the stock market like we may be seeing now, there are two really good options. Sell stocks and raise cash to take advantage ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Boosted the Dow on Tuesday

July 7, 2015: Markets opened slightly higher on Tuesday but a reversal took just moments to set in and U.S. equities traded mostly lower for the remainder of the day. ...
Read Full Story »
Pills

Is Big Pharma Advertising Getting Out of Control?

How much are big pharmaceutical companies really spending to get their drugs out there in the public eye? In 2014, these companies spent about $4.5 billion in advertising alone, notably ...
Read Full Story »
Pills

Short Sellers Become More Focused on Big Pharma

The short interest data has been released for the June 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Prescription drugs

Short Sellers Back Off Big Pharma

The short interest data has been released for the May 29 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »